Please login to the form below

Not currently logged in
Email:
Password:

CombiHIVvac

This page shows the latest CombiHIVvac news and features for those working in and with pharma, biotech and healthcare.

HIV vaccine from J&J starts human trials

HIV vaccine from J&J starts human trials

Scarcity of funding is also threatening a Russian HIV vaccine candidate called CombiHIVvac, which is heading for phase II testing. .

Latest news

  • Russian HIV vaccine heading for phase II trials Russian HIV vaccine heading for phase II trials

    of CombiHIVvac still needs to be approved by the government, reports the RIA Novosti news agency. ... Mikheyev told reporters that the phase II trials planned for CombiHIVvac could take around two years to complete, provided funding can be found.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics